H. Lundbeck A/S (HLUBF)
OTCMKTS · Delayed Price · Currency is USD
5.35
0.00 (0.00%)
Dec 15, 2025, 4:00 PM EST
H. Lundbeck Revenue
H. Lundbeck had revenue of 6.28B DKK in the quarter ending September 30, 2025, with 9.73% growth. This brings the company's revenue in the last twelve months to 24.08B, up 12.30% year-over-year. In the year 2024, H. Lundbeck had annual revenue of 22.00B with 10.51% growth.
Revenue (ttm)
24.08B DKK
Revenue Growth
+12.30%
P/S Ratio
1.72
Revenue / Employee
4.22M DKK
Employees
5,707
Market Cap
6.49B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | 17.67B | 636.00M | 3.73% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| Elite Pharmaceuticals | 122.89M |
| Zomedica | 29.45M |
| Silence Therapeutics | 25.83M |
| Northwest Biotherapeutics | 937.00K |
H. Lundbeck News
- 26 days ago - ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal - Nasdaq
- 27 days ago - Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck - Investor's Business Daily
- 27 days ago - Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid - Seeking Alpha
- 4 weeks ago - Avadel Board Labels Lundbeck Acquisition Bid a Superior Proposal - Nasdaq
- 4 weeks ago - Avadel Board of Directors Declares Lundbeck Proposal a "Company Superior Proposal" - Benzinga
- 4 weeks ago - Avadel Shareholders Wake Up To A Competing Bid For Their Shares - Seeking Alpha
- 4 weeks ago - Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal - Benzinga
- 4 weeks ago - H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - The Wall Street Journal